Cognitive Dysfunction in Multiple Sclerosis (1)
Tuesday, June 21, 2011
Presented By
In less than two decades remarkable advances have been made in the therapeutics of MS, particularly in the development of disease-modifying treatments for relapsing forms of the disease. From no treatment available prior to 1993, the therapeutic armamentarium has expanded to include 8 FDA-approved agents currently marketed in the US. Many other drugs and biologicals are in advanced stages of clinical development, with several having reported successful results in Phase III trials. These have novel mechanisms of action and more desirable routes or frequency of administration than the injectable drugs that have been the mainstay of MS therapy in the 1990s and the first decade of the 21st century. These advances will make the treatment of MS more effective, but also more challenging and complex as MS specialists seek to optimize treatment on an individual basis. While therapeutic activity for relapsing MS has perhaps exceeded that in all of neurology during the past two decades, nonetheless the lack of effective therapy for progressive forms of MS remains a major disappointment. This talk will highlight the currently marketed drugs, describe the new therapeutic agents nearing possible FDA approval, and review the issues that continue to confront investigators in the field.
Reception to follow.
Keynote Speaker
Aaron E. Miller, MD
Mount Sinai School of Medicine
Panelists
Jeffery N. Gingold
MS Patient Advocate
Nicholas G. LaRocca, PhD
National Multiple Sclerosis Society
Cynthia Sitcov
MS Patient Advocate
Registration Pricing
| Member: | $15 |
| Student Member: | $15 |
| Nonmember: | $25 |
| Student Nonmember: | $20 |
Presented by
Gold Sponsors
For a full list of sponsors, please visit the Sponsors tab.
Agenda
*Presentation times are subject to change.
5:00 PM | Registration |
5:30 PM | Welcome Remarks |
5:45 PM | Keynote Address |
6:30 PM | Panel Discussion Moderator: |
7:30 PM | Networking Reception |
Sponsors
For sponsorship opportunities please contact Sonya Dougal at sdougal@nyas.org or 212.298.8682.
Presented by
Gold Sponsors
Grant Support
Academy Friend
National Multiple Sclerosis Society
Promotional Partner
Accelerated Cure Project for Multiple Sclerosis
American Autoimmune Related Diseases Association
American Neurological Association
Consortium of Multiple Sclerosis Centers
European Federation of Neurological Societies (EFNS)
National Multiple Sclerosis Society – NJ Metro Chapter
Travel & Lodging
Our Location
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157
212.298.8600
Hotels Near 7 World Trade Center
Recommended partner hotel:
The New York Academy of Sciences is a part of the Club Quarters network. Please feel free to make accommodations with Club Quarters on-line to save significantly on hotel costs.
Club Quarters Reservation Password: NYAS
Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: (212) 577-1133
Located on the south side of the World Trade Center, opposite Memorial Plaza, Club Quarters, 140 Washington Street, is just a short walk to our location.
Other hotels located near 7 WTC:
212.693.2001 |
212.385.4900 |
212.269.6400 |
212.742.0003 |
212.232.7700 |
212.747.1500 |
212.344.0800 |
Special Needs and Additional Information
For any additional information and for special needs, including child/family care resources available to conference attendees, please e-mail cocampo@nyas.org or call Crystal Ocampo 212.298.8632.